http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2482871-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82753c160799a9b707808bf46f0e00be |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 |
filingDate | 2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d16ce6faa14c04666b2182d9a35ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17649875b2f844f0ed404fb52fb244a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e20656866847b96021c67b99da28ad |
publicationDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2482871-C2 |
titleOfInvention | Composition for treating viral diseases in animals |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to veterinary science, and aims at treating viral diseases in animals. What is declared is a composition for treating viral diseases in animals, containing two subtypes of vertebrate recombinant interferon mixed in equal molar proportions. n EFFECT: use of the declared composition enables ensuring the substantial increase of the therapeutic effect of recombinant interferons and minimising the potential adverse effects associated with their use. n 4 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2780097-C1 |
priorityDate | 2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.